期刊文献+

糖尿病足感染患者病原菌分布及其药物敏感试验 被引量:35

The distribution of causative pathogens and their drug susceptibilities in diabetic foot infections
原文传递
导出
摘要 目的:探讨不同 Wagner 分级的糖尿病足感染的主要病原菌分布及其药物敏感试验特点。方法回顾性分析空军总医院2012年1月至2014年12月收治的705例糖尿病足患者的足部分泌物培养结果,以及药物敏感试验结果。计数资料比较采用χ2检验。结果共收集705例糖尿病足患者1343份标本,细菌培养阳性991份,阳性率为73.8%。其中,革兰阳性菌358株,革兰阴性菌586株,真菌47株;居前三位的细菌依次为铜绿假单胞菌(21.2%)、鲍曼不动杆菌(20.1%)和金黄色葡萄球菌(12.3%)。轻度糖尿病足患者(Wagner 1、2级)革兰阳性菌和革兰阴性菌感染率分别为48.33%(29/60)和46.67%(28/60),中、重度糖尿病足患者(Wagner 3、4、5级)分别为35.34%(329/931)和59.94%(558/931),差异有统计学意义(χ^2=4.324,P=0.038)。轻、中、重度糖尿病足患者病原菌混合感染率分别为3.41%、7.84%和13.84%,差异有统计学意义(χ^2=11.353,P =0.003)。革兰阴性菌中以铜绿假单胞菌、鲍曼不动杆菌感染为主,铜绿假单胞菌对亚胺培南、哌拉西林/他唑巴坦、头孢他啶的敏感率较高,分别为25.84%、24.76%和23.92%;鲍曼不动杆菌对复方新诺明、亚胺培南、头孢哌酮/舒巴坦的敏感率较高,分别为41.71%、25.13%和24.29%。革兰阳性菌以金黄色葡萄球菌、粪肠球菌感染为主,金黄色葡萄球菌对替加环素和万古霉素红的敏感率均为100.00%;粪肠球菌对替加环素和利奈唑胺的敏感率均为100.00%。结论不同程度糖尿病足患者感染的病原菌分布不同,且病原菌对多种抗菌药物敏感性不高。 Objective To investigate the main causative pathogens and their drug susceptibility patterns in diabetic foot infections with different Wagner grades .Methods The bacterial culture results and drug susceptibilities of 705 patients with diabetic foot infections at the Air Force General Hospital from January 2012 to December 2014 were retrospectively analyzed .Enumeration data were compared with Chi‐square test . Results Of 1 343 samples collected from 705 patients with diabetic foot ,991 samples revealed pathogen growth .The positive rate was 73 .8% .In culture‐positive samples ,358 strains were gram‐positive ,586 stains were gram‐negative ,whereas 47 strains were fungi . Pseudomonas aeruginosa , Baumanii and Staphylococcus aureus were dominant .The proportions of gram‐positive and gram‐negative bacteria in patients with Wagner 1 - 2 were 48 .33% (29/60 ) and 46 .67% (28/60 ) ,respectively ,and 35 .34% (329/931) and 59 .94% (558/931) ,respectively in those with Wagner 3 - 5 (χ^2 = 4 .324 , P =0 .038) .The composite infection in patients with mild ,moderate and sever diabetic foot were 3 .41% , 7 .84% ,and 13 .84% , respectively (χ^2 = 11 .353 , P = 0 .003 ) . Among gram‐negative bacteria , Pseudomonas aeruginosa and Baumanii were dominating floras . Susceptibilities of Pseudomonas aeruginosa to imipenem ,piperacillin/tazobactam and ceftazidime were 25 .8% ,24 .76% and 23 .92% , respectively , while susceptibilities of Baumanii to trimethoprim /sulphamethoxazole , imipenem and cefoperazone/sulbactam were 41 .71% ,25 .13% and 24 .29% ,respectively . Staphylococcus aureus and Enterococcus f aecalis were found to be prevalent among gram‐positive bacteria . Staphylococcus aureus was most susceptible to tigecycline and vancomycin (both 100 .00% ) ,and Enterococcus f aecalis was most susceptible to tigecycline and linezolid (both 100 .00% ) .Conclusions The distribution of pathogenic bacteria in diabetic foot infections patients different Wagner grades varies significantly , and causative pathogens are resistant to multiple antimicrobial drugs .
出处 《中华传染病杂志》 CAS CSCD 北大核心 2016年第6期344-348,共5页 Chinese Journal of Infectious Diseases
关键词 糖尿病足 感染 病原菌普 抗菌药 药物敏感性 Diabetic foot Infection Pathogen profile Anti-bacterial agents Drug susceptibility
  • 相关文献

参考文献15

  • 1Xu Y, Wang L, He J, et al. Prevalence and control of diabetes in Chinese adults [J]. JAMA, 2013,310 (9):948- 959. DOI: 10. 1001/jama. 2013. 168118.
  • 2Muller M, Trocme C, Lardy B, et al. Matrix metalloproteinases and diabetic foot ulcers: the ratio of MMP- 1 to TIMP-1 is a predictor of wound healing [J]. Diabet Med, 2008,25 (4): 419-426. DOI: 10. 1111/j. 1464-5491. 2008. 02414. x.
  • 3Pickwell K, Siersma V, Kars M, et al. extremity amputation in patients with an ulcer [J]. Diabetes Care, 2015,38(5) 2337/de14 1598.
  • 4Predictors of lower- infected diabetic foot = 852-857. DOI: 10. Lavery LA, Armstrong DG, Wunderlich RP,et al. Risk factors for foot infections in individuals with diabetes[J]. Diabetes Care, 2006, 29(6):1288 1293. DOI: 10.2337/dc05 2425.
  • 5American Diabetes Association. Peripheral arterial disease in people with diabetes [J]. Diabetes Care, 2003,26 (12) : 3333- 3341. DOI,10. 2337/diacare. 26. 12. 3333.
  • 6Apelqvist J, Bakker K, van Houtum WH, et al. International consensus and practical guidelines on the management and the prevention of the diabetic foot. International Working Group on the Diabetic Foot[J]. Diabetes Metab Res Rev, 2000, 16Suppl 1 :S84-S92. DOI: 10. 1002/1520-7560 (200009/10) 16:1 + ( : : AID-DMRR113:3.0. CO : 2-S.
  • 7Wagner FW Jr. The dysvascular foot: a system for diagnosis and treatment[J]. Foot Ankle, 1981,2(2) :64-122.
  • 8李惠琴,苏晓飞,丁波,罗勇,夏斯桂,马建华.218例糖尿病足患者临床特征及高危因素分析[J].中华内分泌代谢杂志,2012,28(6):492-495. 被引量:36
  • 9关晓宏,刘德辉,冯毅,朱西娥.重度糖尿病足坏疽的感染与抗感染治疗[J].空军总医院学报,1998,14(4):240-242. 被引量:16
  • 10梁乙安,何晓锋.糖尿病足108例分泌物标本细菌培养和药敏分析[J].第四军医大学学报,2006,27(2):189-190. 被引量:26

二级参考文献62

共引文献168

同被引文献216

引证文献35

二级引证文献230

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部